{"entity":{"type":"insider","cik":"0001530197","url":"/insider/0001530197","json_url":"/insider/0001530197.json","name":"Daniels Karen K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2019-03-22","last":"2020-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Daniels Karen K.","source":"filing","n_filings":9,"first_seen":"2019-03-22","last_seen":"2020-11-20"}],"transactions":[{"id":3200029,"accession":"0001593968-20-002229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002229","line_url":"/filing/0001593968-20-002229#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5333.0,"shares_display":"5,333","price_per_share":0.4061,"price_display":"0.41","price_state":"stated","total_value":2165.7313,"total_display":"2,165.73","shares_owned_after":149242.0,"shares_owned_after_display":"149,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-20","scope":"insider"},{"id":2272606,"accession":"0001593968-20-001770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001770","line_url":"/filing/0001593968-20-001770#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5480.0,"shares_display":"5,480","price_per_share":0.8741,"price_display":"0.87","price_state":"stated","total_value":4790.068,"total_display":"4,790.07","shares_owned_after":140664.0,"shares_owned_after_display":"140,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2439179,"accession":"0001593968-20-001222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001222","line_url":"/filing/0001593968-20-001222#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4855.0,"shares_display":"4,855","price_per_share":0.5601,"price_display":"0.56","price_state":"stated","total_value":2719.2855,"total_display":"2,719.29","shares_owned_after":146144.0,"shares_owned_after_display":"146,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-20","scope":"insider"},{"id":2826771,"accession":"0001593968-20-000861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000861","line_url":"/filing/0001593968-20-000861#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6461.0,"shares_display":"6,461","price_per_share":0.3366,"price_display":"0.34","price_state":"stated","total_value":2174.7726,"total_display":"2,174.77","shares_owned_after":150999.0,"shares_owned_after_display":"150,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-19","scope":"insider"},{"id":2716052,"accession":"0001593968-20-000521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000521","line_url":"/filing/0001593968-20-000521#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6229.0,"shares_display":"6,229","price_per_share":0.6035,"price_display":"0.60","price_state":"stated","total_value":3759.2015,"total_display":"3,759.20","shares_owned_after":157460.0,"shares_owned_after_display":"157,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-26","scope":"insider"},{"id":8536705,"accession":"0001593968-19-002187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-002187","line_url":"/filing/0001593968-19-002187#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5421.0,"shares_display":"5,421","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":4499.43,"total_display":"4,499.43","shares_owned_after":163689.0,"shares_owned_after_display":"163,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":7791772,"accession":"0001593968-19-001778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001778","line_url":"/filing/0001593968-19-001778#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5243.0,"shares_display":"5,243","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":5557.58,"total_display":"5,557.58","shares_owned_after":169110.0,"shares_owned_after_display":"169,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":7869268,"accession":"0001593968-19-001171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001171","line_url":"/filing/0001593968-19-001171#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5591.0,"shares_display":"5,591","price_per_share":1.7295,"price_display":"1.73","price_state":"stated","total_value":9669.6345,"total_display":"9,669.63","shares_owned_after":174353.0,"shares_owned_after_display":"174,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":8075379,"accession":"0001593968-19-000836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-000836","line_url":"/filing/0001593968-19-000836#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001530197","owner_name":"Daniels Karen K.","owner_url":"/insider/0001530197","role":"Officer (VP of Operations)","officer_title":"VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13911.0,"shares_display":"13,911","price_per_share":2.3011,"price_display":"2.30","price_state":"stated","total_value":32010.6021,"total_display":"32,010.60","shares_owned_after":179944.0,"shares_owned_after_display":"179,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000887247","name":"Adamis Pharmaceuticals Corp","url":"/issuer/0000887247","role":"Officer (VP of Operations)","n_filings":9,"first_seen":"2019-03-22","last_seen":"2020-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001530197","retrieved_at":"2026-08-22T03:42:54+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}